Updated Jul 16, 2026
LINK WILLIAM J PHD has filed 5 SEC Form 4 filings across 3 companies in the last 90 days — selling. Lifetime open-market sales: $3.18M.

William J. Link, PhD, is a prominent figure in the ophthalmic pharmaceutical industry, serving as a director for several companies including RxSight, Inc. and Tarsus Pharmaceuticals, Inc. He has extensive experience in developing and commercializing innovative therapeutics for eye care.
| Role | Director |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-18 | RXST | RxSight, Inc. | A — Grant or award | 37.0K | — | |
| 2026-06-17 | TARS | Tarsus Pharmaceuticals, Inc. | S — Open-market sale | 1.9K | $62.94 | $121K |
| 2026-06-17 | TARS | Tarsus Pharmaceuticals, Inc. | S — Open-market sale | 10.6K | $61.97 | $655K |
| 2026-06-16 | TARS | Tarsus Pharmaceuticals, Inc. | M — Option exercise | 3.0K | — | |
| 2026-06-05 | LNSR | LENSAR, Inc. | A — Grant or award | 17.4K | $0.00 | |
| 2026-03-18 | TARS | Tarsus Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 493 | $69.75 | $34K |
| 2026-03-18 | TARS | Tarsus Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 8.4K | $69.03 | $578K |
| 2026-03-18 | TARS | Tarsus Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 3.6K | $68.09 | $247K |
| 2025-09-16 | TARS | Tarsus Pharmaceuticals, Inc. | G — Bona-fide gift | 2.0K | $0.00 | |
| 2025-09-08 | TARS | Tarsus Pharmaceuticals, Inc. | S — Open-market sale | 27.1K | $57.00 | $1.55M |
| 2025-06-12 | TARS | Tarsus Pharmaceuticals, Inc. | M — Option exercise | 3.4K | — | |
| 2025-06-03 | RXST | RxSight, Inc. | A — Grant or award | 10.8K | — | |
| 2025-05-23 | LNSR | LENSAR, Inc. | A — Grant or award | 7.4K | $0.00 |
William J. Link, PhD, is a prominent figure in the ophthalmic pharmaceutical industry, serving as a director for several companies including RxSight, Inc. and Tarsus Pharmaceuticals, Inc. He has extensive experience in developing and commercializing innovative therapeutics for eye care.…
5 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 0 open-market purchases () and 6 open-market sales ($3.18M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live LINK WILLIAM J PHD profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.